Project Grant R43MD021487
Award Date 8/6/26
Completion Date 7/31/27
Dollars Obligated $214K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
State College, PA, USA
Similar Awards
- The National Institute for Minority Health and Health Disparities awarded Malama Health, Inc. $1.764 million on September 17, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a specialized risk-stratification platform and tailored diabetes prevention program for postpartum women with a history of gestational diabetes mellitus. The platform will address gaps in current remote monitoring technologies by incorporating contextual glucose information...
- The National Institute for Minority Health and Health Disparities awarded the University of Alabama at Birmingham $201,362 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a continuous metabolic syndrome risk score for the Yup'ik Alaska Native population. The recipient will integrate traditional clinical metabolic syndrome components—waist circumference, blood pressure, fasting plasma glucose, triglycerides, and HDL-cholesterol—with...
- The National Institute for Minority Health and Health Disparities awarded the University of Houston System $445,168 on July 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and validate a depression screening instrument tailored for patients with sickle cell disease. The project addresses a critical diagnostic gap: current screening tools such as the Patient Health Questionnaire-9 fail to distinguish depressive symptoms from somatic symptoms...
- The National Institute on Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $5,959,150 on September 14, 2025, for a randomized controlled trial examining the effectiveness of a food-is-medicine intervention to promote healthy eating and blood pressure control in hypertensive Black women with obesity. The FIM+DASH trial will deliver cooking classes, nutrition and hypertension education, and...
- The National Institute for Minority Health and Health Disparities, part of the National Institutes of Health, awarded Emory University $2,636,940 on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct the MATCH-POINT study, a Type 1 effectiveness-implementation randomized hybrid trial evaluating point-of-care testing (POCT) for sexually transmitted infections among pregnant women. The study addresses escalating STI rates in the United...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Pupil Bio, Inc. $1,015,056 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an early detection test for Type 1 Diabetes using next-generation sequencing analysis of B cell-specific methylation patterns in cell-free DNA. Pupil Bio will refine marker selection to identify methylation patterns ultra-specific to pancreatic islet B cells, building...
- The National Institute for Minority Health and Health Disparities awarded Accuhealth Technologies Incorporated a $311,977 project grant on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to implement and scale the Health360X clinical research platform service for decentralized, point-of-care clinical trials. Accuhealth will develop Health360X as a two-phase effort. Phase I focuses on optimizing electronic health record integration to enable...
- The National Institute for Minority Health and Health Disparities awarded The Regents of the University of California, San Francisco $2,306,030 on September 13, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct research on hypertension retention and cardiovascular risk reduction among people with HIV who use safety-net clinics. The recipient will conduct an explanatory sequential study combining quantitative survey data and qualitative contextual...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $800,434 on August 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a conditional cash transfer and basic needs resolution intervention for low-income adults with Type 2 Diabetes. The award funds research addressing the disproportionate burden of Type 2 Diabetes among individuals living below 133...
- The National Institute for Minority Health and Health Disparities awarded Biotarget DX LLC $295,924 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and validate a dual-platform plasma assay for early lung cancer detection in African American populations. Biotarget DX will integrate FirePlex and CRISPR-ELISA technologies to simultaneously detect ethnicity-specific non-coding RNAs and cytokines as biomarkers for lung cancer...